Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. is the combined entity resulting from the business combination between Health Assurance Acquisition Corp., which traded under the ticker HSAQ, and Orchestra BioMed, a bioelectronic medicine company. Health Assurance Acquisition Corp. completed its IPO in 2020 and was sponsored by Health Assurance Capital LLC, a vehicle associated with healthcare-focused investors. The SPAC targeted the healthcare and medical technology sector, and the July 2022 8-K filing reflects activity tied to the announced merger with Orchestra BioMed, a company developing cardiovascular and bioelectronic therapeutic devices. The combined holding company now carries the Orchestra BioMed Holdings name. Sign up for full SPAC data, filings history, and sponsor analytics on SpacDesk.